CompletedPhase 1NCT00076843
Hu Mik-Beta-1 to Treat HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis
Studying Tropical spastic paraparesis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Institute of Neurological Disorders and Stroke (NINDS)
- Principal Investigator
- Steven Jacobson, Ph.D.National Institute of Neurological Disorders and Stroke (NINDS)
- Intervention
- Hu MiK-Beta-1(drug)
- Enrollment
- 9 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2004 – 2019
Study locations (1)
- National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00076843 on ClinicalTrials.govOther trials for Tropical spastic paraparesis
Additional recruiting or active studies for the same condition.